Commerzbank Aktiengesellschaft’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-612,886
| Closed | -$7.62M | – | 1035 |
|
|
2016
Q4 | $7.62M | Sell |
612,886
-11,302
| -2% | -$136K | 0.11% | 167 |
|
|
2016
Q3 | $8.54M | Sell |
624,188
-5,006
| -0.8% | -$50.3K | 0.14% | 140 |
|
|
2016
Q2 | $4.65K | Buy |
629,194
+232
| +0% | +$1.74K | 0.03% | 244 |
|
|
2016
Q1 | $4.02M | Buy |
628,962
+605,067
| +2,532% | +$3.39M | 0.03% | 270 |
|
|
2015
Q4 | $149K | Buy |
+23,895
| New | +$157K | ﹤0.01% | 1081 |
|
|
2015
Q3 | – | Sell |
-48,294
| Closed | -$399K | – | 1213 |
|
|
2015
Q2 | $399K | Buy |
48,294
+4,367
| +10% | +$38.6K | ﹤0.01% | 1030 |
|
|
2015
Q1 | $362K | Sell |
43,927
-316,200
| -88% | -$2.34M | ﹤0.01% | 1011 |
|
|
2014
Q4 | $2.47M | Sell |
360,127
-76,257
| -17% | -$477K | 0.02% | 602 |
|
|
2014
Q3 | $2.36M | Sell |
436,384
-112,094
| -20% | -$655K | 0.01% | 696 |
|
|
2014
Q2 | $3.49M | Buy |
548,478
+220,604
| +67% | +$1.52M | 0.02% | 576 |
|
|
2014
Q1 | $2.64M | Buy |
327,874
+206,412
| +170% | +$1.61M | 0.01% | 638 |
|
|
2013
Q4 | $898K | Buy |
121,462
+91,993
| +312% | +$497K | ﹤0.01% | 917 |
|
|
2013
Q3 | $542K | Buy |
29,469
+11,429
| +63% | +$222K | ﹤0.01% | 964 |
|
|
2013
Q2 | $316K | Buy |
+18,040
| New | +$320K | ﹤0.01% | 1224 |
|
Other funds holding ARIA
Commerzbank Aktiengesellschaft's ARIA Position: Q1 2017 in Review
Commerzbank Aktiengesellschaft sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 612,886 shares — an estimated $7.62M sold.
Commerzbank Aktiengesellschaft first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $8.54M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Commerzbank Aktiengesellschaft reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Commerzbank Aktiengesellschaft sold 612,886 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $7.62M.
- Commerzbank Aktiengesellschaft first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
- Commerzbank Aktiengesellschaft's Ariad Pharmaceuticals Inc position peaked at $8.54M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.